if you can't quantify it, you can't manage it

In the knowledge-driven, increasingly competitive global world, the difference between a leader and a follower is to see and know changes faster, and above all, to USE this knowledge earlier than the others. Knowledge, agility and speed in executing do shape the winner.

PHARMAWISER™ Simulator, a next generation price optimization software, is designed to continuously be on top of any change. This radical invention in the field of sequential dynamic scenario planning, where all meaningful business events and marketing drivers can be continuously updated, makes it possible to immediately predict the cross border impact of any market place change, any change in pricing regulations and pricing algorithms or any strategic move. Maximally tailored for each product, each indication. With specifics for each country, it measures impact on each custom universe of countries or regions, pan-European, American or globally.

PHARMAWISER™ Simulator is a powerful, myth-breaking, versatile and cost-saving scenario planning engine for anyone dealing with Pharmaceutical Economics, thus the full scope of the pharma commercialization process. In particular functions in Pricing & Market Access, Strategic Marketing and Business Development can exploit to the fullest all available in-house Business Intelligence and Health Economics expertise.

Vastly innovating in many areas, PHARMAWISER™ Simulator is the transformational cross-functional strategic pricing, marketing planning and forecasting engine by excellence: By integrating the right pieces of data from the massive silo's of information residing within the company, it makes sense of it all. This smart analytic framework enhances cross-functional communication and reduces data redundance while highlighting where the true Business Intelligence gaps are. It increases both productivity and quality tremendously through simplifying the entire commercial planning process. By imbedding P&R impacts right from the start in the scenario forecast a 2-way 'volume/price' resulting margin helps in guiding towards the better strategy.

Ready for national and international use.


Made transparant and simple as a game, now also in Pharma, you can ‘play’ your way to success with the unique PHARMAWISER™ Simulator, the newest knowledge technology to steer strategy towards higher profitability.

Fully compliant with US and European International Trade legislation!

Read more <

Functions that are empowered by PHARMAWISER™ Simulator:

• Global brand manager 

• Brand team members

• Global strategic product or marketing manager

• Any managerial position in Pharmaceutical Economics

• Pricing, P&R or Market Access manager

• Managing Director

• Business Development manager (M&A and Licensing)

• Therapeutic area leader

• Portfolio manager

• Business Intelligence manager

• Business Analyst

• Market Research executives

• Forecasting manager

• Operational area executives

• International Demand or Production manager

Lifecycle Management (LCM) situations where PHARMAWISER™ Simulator can support your strategy:

• LCM and POST-EXPIRY When brand x is challenged by a generic: Quantify the amount of estimated value/profit destruction. Assessment of global effect, given spill-over on other countries. What are possible scenario's and which is best country-by-country pricing strategy post-expiry?

• AT LAUNCH For a new brand or new label extension: How does price, country mix or country launch sequence influence the local country and global result? What is the best launch sequence for a specific product with a specific price in a specific country universe?

• AT LAUNCH and LCM How will the initial launch price evolve over time considering the subsequent launches in other countries and the interdependent effects of price referencing -both national and international- and parallel import?

• AT LAUNCH and LCM How to determine the right balance between market share (volume) and price given market forces of price elasticity of demand, cross-border trade (parallel import) and referencing?

• AT LAUNCH and LCM How to quantify the global effect of other local pricing impacts on profits such as discounts, imposed price decrease, risk-sharing, drug licenses, dose-capping, profit ceiling and other innovative pricing initiatives?

• AT LAUNCH and LCM What is the net impact of Parallel Import, post optimization for effects of International Price Referencing? How to legally curtail PI through clever country pricing?

• FROM LAB TO LAUNCH How to fast assess the volume potential of in-licensing or pipeline products according to their potential label and price scenario’s?

• FROM LAB TO LAUNCH How to tailor P&R strategy to possible labeling outcomes? What is the best price/label scenario?

• FROM LAB TO LAUNCH TO LCM How to account for varying information availability at different stages of the new product launch and gradually build up a more finetuned forecast at each stage?

• LAUNCH TO LCM To what extent will international price referencing offset the impact of parallel trade?

• LAUNCH TO LCM To what extent will international price referencing offset the impact of parallel trade?

• FROM LAB TO LAUNCH TO LCM What consequence does a country's price elasticity of demand (both inter-brand and intra-brand)have on the global price & profit picture? What is the optimal country specific price/volume target in view of global margin?

• FROM LAB TO LAUNCH TO LCM How to account for varying information availability at different stages of the new product launch and gradually build up a more finetuned forecast at each stage?

• FROM LAB TO LAUNCH TO LCM How to avoid amazingly different forecasts for the same product depending on which department is the forecast originator.

• LAUNCH TO LCM How to harmonize short-range operational budget planning and long-range strategic planning?

• FROM LAB TO LAUNCH TO LCM How to integrate market intelligence, brand management & pricing/health economics inputs in the product planning and forecasting process?

"Having a clean, robust, single version of the truth is the starting point. Without that you're putting lipstick on a pig." Mandeep Hansra

Read more <